S

Synthetic Biologics, Inc.

17 employees

Synthetic Biologics is a biotechnology company developing biologics for the prevention and treatment of serious infectious diseases.

Basic info

biotechnology

Biotechnology

Clinical Development

Therapeutics

Microbiome

Drug discovery

Irritable Bowel Syndrome with Constipation (IBS-C)

Health Care

Preservation of natural gut microbiome

Prevention of C. dificile Infection

2001

$12M

from 2 investors over 2 rounds

S

Synthetic Biologics, Inc. raised $12M on September 12, 2017

Investors: BDT & MSD Partners

S

Synthetic Biologics, Inc. raised $5.6M on September 23, 2013

Investors: EPSRC